These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23114776)

  • 21. N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.
    Eroshenko D; Polyudova T; Korobov V
    Microb Pathog; 2017 Apr; 105():145-152. PubMed ID: 28237766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against
    Kart D; Kustimur AS; Sağıroğlu M; Kalkancı A
    Balkan Med J; 2017 Dec; 34(6):546-552. PubMed ID: 29215338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
    Rolston KV; Ho DH; LeBlanc B; Streeter H; Dvorak T
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
    Gimeno C; Borja J; Navarro D; Valdés L; García-Barbal J; García-de-Lomas J
    Chemotherapy; 1998; 44(2):94-8. PubMed ID: 9551238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
    Eliopoulos GM; Wennersten CB; Moellering RC
    Diagn Microbiol Infect Dis; 1996 May; 25(1):35-41. PubMed ID: 8831043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
    Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N
    Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
    Rolston KV; Frisbee-Hume S; LeBlanc BM; Streeter H; Ho DH
    Diagn Microbiol Infect Dis; 2002 Oct; 44(2):187-94. PubMed ID: 12458127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antimicrobial activity of silver-processed catheters for neurosurgery.
    Bayston R; Vera L; Mills A; Ashraf W; Stevenson O; Howdle SM
    J Antimicrob Chemother; 2010 Feb; 65(2):258-65. PubMed ID: 19942617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocide activity against urinary catheter pathogens.
    Malic S; Jordan RP; Waters MG; Stickler DJ; Williams DW
    Antimicrob Agents Chemother; 2014; 58(2):1192-4. PubMed ID: 24247129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.
    Credito K; Lin G; Koeth L; Sturgess MA; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Feb; 53(2):814-7. PubMed ID: 19015359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of levofloxacin against gram-positive bacteria.
    Montanari MP; Mingoia M; Marchetti F; Varaldo PE
    Chemotherapy; 1999; 45(6):411-7. PubMed ID: 10567771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
    Noviello S; Ianniello F; Leone S; Esposito S
    Infez Med; 2006 Mar; 14(1):24-8. PubMed ID: 17405239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms.
    Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):655-9. PubMed ID: 23642281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial susceptibility surveillance of recent isolates from ophthalmological infections to gatifloxacin and other antimicrobial drugs].
    Matsuzaki K; Koyama H; Watabe E; Hasegawa M; Sato Y; Kobayashi I
    Jpn J Antibiot; 2005 Feb; 58(1):45-9. PubMed ID: 15847222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review: Efficacy of antimicrobial-impregnated catheters in external ventricular drainage - a systematic review and meta-analysis.
    Wang X; Dong Y; Qi XQ; Li YM; Huang CG; Hou LJ
    Crit Care; 2013 Jul; 17(4):234. PubMed ID: 23890254
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Vargas-Cruz N; Reitzel RA; Rosenblatt J; Jamal M; Szvalb AD; Chaftari AM; Hachem R; Raad I
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study.
    Hoban DJ; Bouchillon SK; Johnson JL; Zhanel GG; Butler DL; Miller LA; Poupard JA;
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):814-9. PubMed ID: 11783700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.
    Cormican MG; Jones RN
    Antimicrob Agents Chemother; 1997 Jan; 41(1):204-11. PubMed ID: 8980783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.